Finance

Lists
Why is BVF down 3,41%?
Dive Deeper
BVF:FRA
Bausch Health Companies Inc
4,70 €
-3,41%
(-0,17) 1D
25 սեպ, 08:05:10 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BVF...
Open
4,70 €
High
4,70 €
Low
4,70 €
Mkt. cap
2,12 մլրդ
Avg. vol.
41,00
Volume
0,00
52-wk high
6,57 €
52-wk low
3,66 €
No. of employees
20 հզր
Open
4,70 €
High
4,70 €
Low
4,70 €
Mkt. cap
2,12 մլրդ
Avg. vol.
41,00
Volume
0,00
52-wk high
6,57 €
52-wk low
3,66 €
No. of employees
20 հզր
News stories
From web sources and news partners
Profile
Bausch Health Companies Inc. is a global, diversified Canadian pharmaceutical company. Its global corporate headquarters are located in Laval, Quebec, Canada, and its U.S. headquarters are in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals. Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees20,3 հզր
Founded1959
HeadquartersԼավալ, Քվեբեկ, Կանադա
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
2,68 մլրդ
2,80 մլրդ
2,52 մլրդ
2,85 մլրդ
Cost of goods sold
750,00 մլն
798,00 մլն
738,00 մլն
772,00 մլն
Cost of revenue
750,00 մլն
798,00 մլն
738,00 մլն
772,00 մլն
Research and development expenses
166,00 մլն
161,00 մլն
163,00 մլն
173,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
795,00 մլն
880,00 մլն
860,00 մլն
907,00 մլն
Operating expense
1,21 մլրդ
1,28 մլրդ
1,26 մլրդ
1,30 մլրդ
Total operating expenses
1,96 մլրդ
2,08 մլրդ
2,00 մլրդ
2,08 մլրդ
Operating income
717,00 մլն
721,00 մլն
521,00 մլն
775,00 մլն
Other non operating income
-
-
-
-
EBT including unusual items
218,00 մլն
56,00 մլն
-1,35 մլրդ
348,00 մլն
EBT excluding unusual items
313,00 մլն
322,00 մլն
118,00 մլն
383,00 մլն
Income tax expense
37,00 մլն
159,00 մլն
77,00 մլն
88,00 մլն
Effective tax rate
16,97%
283,93%
-5,69%
25,29%
Other operating expenses
-
-
1,00 մլն
-
Net income
179,00 մլն
-112,00 մլն
-1,42 մլրդ
258,00 մլն
Net profit margin
6,68%
-4,01%
-56,38%
9,05%
Earnings per share
1,16
1,10
0,78
1,26
Interest and investment income
15,00 մլն
9,00 մլն
10,00 մլն
11,00 մլն
Interest expense
-412,00 մլն
-397,00 մլն
-402,00 մլն
-396,00 մլն
Net interest expenses
-397,00 մլն
-388,00 մլն
-392,00 մլն
-385,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,02 մլրդ
1,01 մլրդ
816,00 մլն
1,06 մլրդ
Gain or loss from assets sale
-6,00 մլն
-
-3,00 մլն
-
AI content may include mistakes. Learn more
Google Apps